OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma
Walter J. Storkus, Deena M. Maurer, Yan Lin, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003675-e003675
Open Access | Times Cited: 36
Walter J. Storkus, Deena M. Maurer, Yan Lin, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 11, pp. e003675-e003675
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations
Lisa H. Butterfield, Yana G. Najjar
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 399-416
Closed Access | Times Cited: 98
Lisa H. Butterfield, Yana G. Najjar
Nature reviews. Immunology (2023) Vol. 24, Iss. 6, pp. 399-416
Closed Access | Times Cited: 98
The Current State of Treatment and Future Directions in Cutaneous Malignant Melanoma
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46
Madison Ernst, Alessio Giubellino
Biomedicines (2022) Vol. 10, Iss. 4, pp. 822-822
Open Access | Times Cited: 46
Natural peptides for immunological regulation in cancer therapy: Mechanism, facts and perspectives
Yunchao Zhang, Chenxin Liu, Chunjie Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114257-114257
Open Access | Times Cited: 27
Yunchao Zhang, Chenxin Liu, Chunjie Wu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 159, pp. 114257-114257
Open Access | Times Cited: 27
Impaired function of dendritic cells within the tumor microenvironment
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
Zhihua Xiao, Ruiqi Wang, Xuyan Wang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
The role of dendritic cells in cancer immunity and therapeutic strategies
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Yunze Tai, Man Chen, Fang Wang, et al.
International Immunopharmacology (2024) Vol. 128, pp. 111548-111548
Closed Access | Times Cited: 11
Analysis of the Correlation and Prognostic Significance of Tertiary Lymphoid Structures in Breast Cancer: A Radiomics‐Clinical Integration Approach
Kezhen Li, Juan Ji, Simin Li, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 4, pp. 1206-1217
Closed Access | Times Cited: 14
Kezhen Li, Juan Ji, Simin Li, et al.
Journal of Magnetic Resonance Imaging (2023) Vol. 59, Iss. 4, pp. 1206-1217
Closed Access | Times Cited: 14
Tertiary lymphoid structures in cancer: immune mechanisms and clinical implications
Siyu Wang, Hua Wang, Chenbei Li, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 5
Siyu Wang, Hua Wang, Chenbei Li, et al.
MedComm (2024) Vol. 5, Iss. 3
Open Access | Times Cited: 5
Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette–Guérin Immunotherapy of Bladder Cancer
Omar M. Ibrahim, Paweł Kaliński
Cells (2024) Vol. 13, Iss. 8, pp. 699-699
Open Access | Times Cited: 5
Omar M. Ibrahim, Paweł Kaliński
Cells (2024) Vol. 13, Iss. 8, pp. 699-699
Open Access | Times Cited: 5
The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Gabriel Cabrera, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 22
Noncoding RNAs in the Glycolysis of Ovarian Cancer
Chunmei Zhang, Ning Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Chunmei Zhang, Ning Liu
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
Comprehensive analysis of EphA2 in pan‐cancer: A prognostic biomarker associated with cancer immunity
Yuchun Li, Hanxiao Fei, Zhiwen Xiao, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 8
Closed Access | Times Cited: 4
Yuchun Li, Hanxiao Fei, Zhiwen Xiao, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 8
Closed Access | Times Cited: 4
A Phase I, First‐In‐Human Study of CBA ‐1205, an Anti‐DLK1 Monoclonal Antibody, in Patients With Advanced Solid Tumors
Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama, et al.
Cancer Science (2025)
Open Access
Yuki Katsuya, Masafumi Ikeda, Takafumi Koyama, et al.
Cancer Science (2025)
Open Access
Neue systemische Therapieansätze beim Bindehautmelanom
Florian T. Steinberg, Michael S. Simon, P. Reimer, et al.
Deleted Journal (2025)
Closed Access
Florian T. Steinberg, Michael S. Simon, P. Reimer, et al.
Deleted Journal (2025)
Closed Access
Role and Function of Receptor Tyrosine Kinases in BRAF Mutant Cancers
Bernhard Biersack, Lubna H. Tahtamouni, Michael Höpfner
Receptors (2024) Vol. 3, Iss. 1, pp. 58-106
Open Access | Times Cited: 3
Bernhard Biersack, Lubna H. Tahtamouni, Michael Höpfner
Receptors (2024) Vol. 3, Iss. 1, pp. 58-106
Open Access | Times Cited: 3
A novel extrachromosomal circular DNA related genes signature for overall survival prediction in patients with ovarian cancer
Ying Zhang, Kexian Dong, Xueyuan Jia, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Ying Zhang, Kexian Dong, Xueyuan Jia, et al.
BMC Medical Genomics (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 8
Listeria-based vaccination against the pericyte antigen RGS5 elicits anti-vascular effects and colon cancer protection
Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Trevor S. Anderson, Amanda L. McCormick, Elizabeth A. Daugherity, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 7
Combined treatment of small cell lung cancer using radiotherapy and immunotherapy: Challenges and updates
Zhumin Cao, Kai Deng, Jinxiu Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117727-117727
Closed Access | Times Cited: 2
Zhumin Cao, Kai Deng, Jinxiu Jiang, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 182, pp. 117727-117727
Closed Access | Times Cited: 2
Dendritic cell vaccines as cancer treatment: focus on 13 years of manufacturing and quality control experience in Advanced Therapy Medicinal Products
Anna Maria Granato, Elena Pancisi, Claudia Piccinini, et al.
Cytotherapy (2024) Vol. 26, Iss. 12, pp. 1547-1555
Open Access | Times Cited: 2
Anna Maria Granato, Elena Pancisi, Claudia Piccinini, et al.
Cytotherapy (2024) Vol. 26, Iss. 12, pp. 1547-1555
Open Access | Times Cited: 2
Targeting the EphA2 pathway: could it be the way for bone sarcomas?
G Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
G Giordano, Cristina Tucciarello, Alessandra Merlini, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Current “state of the art” on dendritic cell-based cancer vaccines in melanoma
Julia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, et al.
Current Opinion in Oncology (2023)
Open Access | Times Cited: 5
Julia Katharina Schwarze, Xenia Geeraerts, Sandra Tuyaerts, et al.
Current Opinion in Oncology (2023)
Open Access | Times Cited: 5
Immune approaches beyond traditional immune checkpoint inhibitors for advanced renal cell carcinoma
Albert Jang, Jake Lichterman, Jeffrey Y. Zhong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Albert Jang, Jake Lichterman, Jeffrey Y. Zhong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 3
Open Access | Times Cited: 5
Trends in Melanoma Phase 3 Clinical Trials since 2010: Is there Hope for Advanced Melanoma Therapies beyond Approved Treatment Mechanisms?
Hanna Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5184-5184
Open Access | Times Cited: 8
Hanna Kakish, Fasih Ali Ahmed, Mohamedraed Elshami, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5184-5184
Open Access | Times Cited: 8
Targeting the pericyte antigen DLK1 with an alpha type-1 polarized dendritic cell vaccine results in tumor vascular modulation and protection against colon cancer progression
Amanda L. McCormick, Trevor S. Anderson, Elizabeth A. Daugherity, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Amanda L. McCormick, Trevor S. Anderson, Elizabeth A. Daugherity, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Tertiary lymphoid structures as potential biomarkers for cancer prediction and prognosis
Xin Zhang, Jie Yao, Mei Xie, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112790-112790
Open Access | Times Cited: 1
Xin Zhang, Jie Yao, Mei Xie, et al.
International Immunopharmacology (2024) Vol. 140, pp. 112790-112790
Open Access | Times Cited: 1
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
Mark DeBenedette, Alicia Gamble, Marcus S. Norris, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
Mark DeBenedette, Alicia Gamble, Marcus S. Norris, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
